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Background: A high proportion of patients undergoing PCI are readmitted within 30 days of discharge. Since these patients are at increased risk 
of adverse events, we developed a risk score that can identify PCI patients at higher risk of readmission.
methods: The sample included patients who underwent PCI at a CathPCI Registry®-participating hospital that were linked with 100% Medicare Part 
A data between 1/2007 and 1/2009. The sample (n=388,078) was randomly divided into development (n=193,899) and validation (n=194,179) 
cohorts. We counted all readmissions that were not associated with staged revascularization procedures. Multivariable logistic regression models 
using stepwise selection models identified variables associated with all-cause 30-day readmission. Each covariate with a significant effect and 
rounded odds ratio (OR) ≥1.2 was assigned an integer score based on beta estimates.
results: The mean 30-day readmission rate was 11.36%. In total, 19 variables were significantly associated with risk of 30-day readmission 
(p<0.05), and model c-statistics were similar in the development (0.61) and validation (0.60) cohorts. The simple risk score based on 14 variables 
identified patients at high and low risk of readmission (Table).
conclusion: Among PCI patients, risk of readmission can be estimated using clinical factors present at the time of the procedure. This risk score 
may help to guide clinical decision-making and resource allocation for PCI patients at the time of hospital discharge. 
Table: Risk Scores and Factors Associated with 30-day Readmission, Development Cohort
PointsRisk Factor OR* 95% CI
Age
(67-68] 1.233 [1.182,1.286] 1
(68-69] 1.445 [1.380,1.513] 3
(69+] 1.593 [1.505,1.686] 5
Female
Yes 1.265 [1.228,1.303] 2
BMI
<=15 1.212 [1.171,1.255] 1
HF-previous history
Yes 1.326 [1.274,1.381] 2
Previous valvular surgery
Yes 1.188 [1.079,1.307] 1
Peripheral Vascular Disease
Yes 1.227 [1.182,1.274] 1
Chronic Lung Disease
Yes 1.496 [1.446,1.548] 4
Diabetes
Insulin diabetes 1.399 [1.338,1.463] 3
GFR
GFR<30 1.749 [1.629,1.879] 6
30<=GFR<60 1.204 [1.165,1.245] 1
Renal failure - dialysis
Yes 1.56 [1.420,1.714] 5
HF - current status
Yes 1.334 [1.280,1.390] 2
Symptoms on admission
MI after 24 hrs 1.16 [1.095,1.229] 1
EF percentage
Not measured 1.181 [1.142,1.222] 1
EF<30 1.528 [1.434,1.627] 4
30<=EF<45 1.225 [1.172,1.280] 1
PCI status
Urgent 1.391 [1.345,1.438] 3
Emergency 1.525 [1.441,1.615] 4
Salvage 1.638 [1.205,2.226] 5
*p<0.001 for all variables with the exception of PCI Salvage (p=0.002)
Distribution of Score Range and Predicted Probability
Development Cohort Validation Cohort
Readmission Readmission
Score n (%) % n (%) %
0 411 (0.2) 10.0 375 (0.2) 9.6
1-3 29,402 (15.2) 8.4
29,100 
(15.0)
8.4
4-6 51,437 (26.5) 10.8
51,022 
(26.3)
10.7
Mean readmission rate=11.36%
7-9 49,247 (25.4) 13.3
49,839 
(25.7)
13.3
10-12 33,536 (17.3) 16.2
33,873 
(17.5)
16.3
13-15 17,417 (9.0) 20.6 17,450 (9.0) 20.2
16+ 12,449 (6.4) 26.9 12,520 (6.5) 25.8
